- Comparative evaluation of three proliferation markers🔍
- Ki|67 regulates global gene expression and promotes ...🔍
- Breast Cancer Biomarkers🔍
- High Ki67 expression is an independent good prognostic marker in ...🔍
- The role of Ki|67 in breast cancer🔍
- Ki67 and P53 expression in breast cancer and their correlation with ...🔍
- Identification of biomarkers and potential therapeutic targets for ...🔍
- Ki|67 Is an Independent Predictor of Bladder Cancer Outcome in ...🔍
Marker Ki|67 is a potential biomarker for the diagnosis and ...
Comparative evaluation of three proliferation markers, Ki-67, TOP2A ...
We chose TOP2A because it is used for breast cancer diagnostics and because, as a target for anthracyclines and topoisomerase II inhibitors, it ...
Ki-67(MIB-1), Breast, Quantitative Immunohistochemistry, Automated
Ki-67 (MIB-1 clone) is a monoclonal antibody that reacts with cells undergoing DNA synthesis by binding to the Ki-67 antigen, a marker known to be expressed ...
Ki-67 regulates global gene expression and promotes ... - PNAS
Ki-67 is a nuclear protein present in all proliferating vertebrate cells and is widely used as a marker in clinical cancer histopathology.
Breast Cancer Biomarkers | Choose the Right Test - ARUP Consult
Immunohistochemistry 4 (IHC4) scores may be useful in postmenopausal patients with node-negative cancer or with 1-3 positive nodes, as long as ...
High Ki67 expression is an independent good prognostic marker in ...
Finally, our findings strongly argue for a clinical utility of Ki67 immunostaining as an independent prognostic biomarker in CRC. ... Effect of tumor ...
The role of Ki-67 in breast cancer
The proliferative marker, Ki-67, is a human nuclear antigen, and forms an integral part of cell division in both normal and malignant tissue.
Ki67 and P53 expression in breast cancer and their correlation with ...
Conclusion: Ki67 and P53 may be considered as a valuable biomarker in breast cancer patients which can help in planning treatment ... markers and potential in ...
Identification of biomarkers and potential therapeutic targets for ...
Pancreatic cancer (PC) is the deadliest malignancy due to late diagnosis. Aberrant alterations in the blood proteome might serve as biomarkers to facilitate ...
Ki-67 Is an Independent Predictor of Bladder Cancer Outcome in ...
Abstract. Purpose: To determine the association of the cell proliferative marker Ki-67 with pathologic features and disease prognosis in ...
Is Overexpression of Ki-67 a Prognostic Biomarker of Upper Tract ...
Background: Upper tract urinary carcinoma (UTUC) is a relatively uncommon but aggressive disease. The Ki-67 antigen is a classic marker of ...
Prognostic and clinicopathologic value of ki-67 and profilin 1 ...
Ki-67 is a highly predictive biomarker for recurrence-free, progression-free, and cancer-specific survival in pT1 bladder cancer patients.
Grades and the Ki-67 index - Cancer Research UK
The grade and the Ki-67 index gives your doctor an idea of how the neuroendocrine tumour (NET) might behave and whether it is likely to spread.
Test Definition: KI67B - Mayo Clinic Laboratories
... Biomarker and Image Analysis Laboratory, Department of ... Urruticoechea A, Smith IE, Dowsett M: Proliferation marker Ki-67 in early breast cancer.
Ki-67: A Nuclear Antigen Uniquely Qualified as a Marker of Cellular ...
Beyond its use in diagnosis and prognostic determinations of varied neoplasms, Ki-67 labeling index, or the percentage of immunoreactive cell nuclei, has ...
Standardization with Clinical Digital Pathology - The Ki-67 Case
... Ki-67 Case Webinar Abstract: The nuclear proliferation biomarker Ki-67 has multiple potential roles in breast and other cancers, both as a ...
Learn how the prostate specific antigen (PSA) blood test can help to diagnose prostate problems, the pros and cons of the test, what the results mean, ...
Prostate-Specific Antigen (PSA) Test - NCI
Learn what a PSA test is, plus the limitations and potential harms of the test when used to screen for prostate cancer.
Difference Between the Ki-67 Tumor Marker Test and the Oncotype ...
Dr. Harness explains the difference between the Ki-67 test and Oncotype DX test. The Ki-67 test determines how rapidly cells are growing and ...
The atlas for all human proteins in cells and tissues using various omics: antibody-based imaging, transcriptomics, MS-based proteomics, and systems biology ...
Full Program - San Antonio Breast Cancer Symposium
... Ki-67 in Predicting Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial. Xiaoxi Pan, Institute of Cancer Research ...